IN10018 Combination Therapy in Treatment-naïve ES-SCLC
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Recruiting · NCT06030258 · Registry updated 2025-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IN10018 Combination Therapy in Treatment-naïve ES-SCLC | Small Cell Lung Cancer Extensive Stage | Recruiting | Phase 1 / Phase 2 | 2025-04-30 | NCT06030258 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InxMed (Shanghai) Co., Ltd. | 10 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Provincial People's Hospital | Zhengzhou | China | 21 |
| Shandong Province Cancer Hospital | Jinan | China | 1 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 50 |